Phase 3 registrational trials evaluating petosemtamab in combination with pembrolizumab in 1L and petosemtamab monotherapy in 2/3L r/m HNSCC enrolling…
Late-breaking presentation highlights the pTau217 assay as an effective and efficient tool to screen participants for ALTITUDE-AD that reduces unnecessary…
BURLINGTON, Mass., Oct. 30, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of a long-read Whole Genome…
DELRAY BEACH, Fla., Oct. 30, 2024 /PRNewswire/ -- The global biosimulation market is projected to reach USD 9.18 billion by 2029…
Communities in Highly Regulated Industries Rely on Trusted, Proven Solution to Collaborate Securely and Compliantly HERNDON, Va., Oct. 30, 2024…
Collaboration Will Expand Awareness of Movano's Female First Wearable to D'Amelio's 12 Million Social Media Followers PLEASANTON, Calif., Oct. 30,…
COLUMBIA, Md., Oct. 30, 2024 /PRNewswire/ -- Advarra, the market leader in regulatory review solutions and clinical research technology for sites,…
PRINCETON, N.J., Oct. 30, 2024 /PRNewswire/ -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research,…
PHILADELPHIA, Oct. 30, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, today announced a…
Former PathAI Business Development Senior Director Hamza Sheikh Joins Company to Support Growing Customer Base and Strengthen Global Impact BOSTON,…